TechFlow news, July 18 — According to GlobeNewswire, Basel Medical Group (Nasdaq: BMGL) announced the suspension of its acquisition of BTC digital assets. This decision follows thorough discussions with the Bitcoin Holders Alliance and is primarily due to ongoing regulatory scrutiny of digital assets by U.S. authorities and uncertainties surrounding current policy directions that could impact the transaction. Both parties agree that deferring the transaction until the regulatory environment becomes clearer is more prudent, and they will continue to closely monitor regulatory developments and reassess the acquisition opportunity once conditions become clearer.
Add to Favorites
Share to Social Media
